Literature DB >> 16422826

Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study.

William A Fisher1, Raymond C Rosen, Ian Eardley, Michael Sand, Irwin Goldstein.   

Abstract

INTRODUCTION: Much research has explored the experience of erectile dysfunction (ED) among men with ED, but far less attention has been paid to the perceptions and sexual experiences of the female partners of men with ED. AIM: The objective of this study was to characterize the attitudes, beliefs, and sexual experience of female partners of men with erectile difficulties.
METHODS: Female partners of men with ED who had participated in the Men's Attitudes to Life Events and Sexuality (MALES) study were recruited for this research via mail or Internet, after their male partners consented to this contact. Female partners of men with ED (N = 293) responded to questionnaire measures assessing their frequency of sexual activity and the nature of their sexual experience, both before and after the development of their partner's ED, and in relation to their partner's use of phosphodiesterase type 5 (PDE5) inhibitors.
RESULTS: Women reported engaging in sexual activity significantly less frequently after their partner developed ED in comparison with before (P < 0.001). Moreover, significantly fewer women experienced sexual desire, arousal, or orgasm "almost always" or "most times," and significantly fewer women reported satisfaction with their sexual relationship after their partner developed ED, compared with before (P < 0.001). Decreases in female sexual satisfaction and frequency of orgasm were significantly related to the male partner's self-reported severity of ED (P < 0.01). The proportion of women who experienced sexual desire, arousal, and orgasm "almost always" or "most times" was significantly higher in the group whose partners were currently using a PDE5 inhibitor (P < 0.05).
CONCLUSION: Erectile dysfunction has significant adverse effects on the female partner's sexual experience. Women with partners who were currently using PDE5 inhibitors had a more satisfying sexual experience than those whose partners did not use a PDE5 inhibitor.

Entities:  

Mesh:

Year:  2005        PMID: 16422826     DOI: 10.1111/j.1743-6109.2005.00118.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  37 in total

1.  Sexual touching and difficulties with sexual arousal and orgasm among U.S. older adults.

Authors:  Adena M Galinsky
Journal:  Arch Sex Behav       Date:  2011-12-08

2.  Correlates of PDE5i use among subjects with erectile dysfunction in two population-based surveys.

Authors:  Thomas G Travison; Susan A Hall; William A Fisher; Andre B Araujo; Raymond C Rosen; John B McKinlay; Michael S Sand
Journal:  J Sex Med       Date:  2011-08-11       Impact factor: 3.802

3.  Effects of nasal continuous positive airway pressure therapy on partners' sexual lives.

Authors:  Mustafa Acar; Coskun Kaya; Tolgahan Catli; Deniz Hancı; Ozge Bolluk; Yunus Aydin
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-10       Impact factor: 2.503

4.  Current Diagnosis and Management of Erectile Dysfunction.

Authors:  Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2014-09

Review 5.  [Female sexual dysfunction].

Authors:  J B Korda
Journal:  Urologe A       Date:  2008-01       Impact factor: 0.639

6.  Changes in sexual function among midlife women: "I'm older… and I'm wiser".

Authors:  Holly N Thomas; Megan Hamm; Rachel Hess; Rebecca C Thurston
Journal:  Menopause       Date:  2018-03       Impact factor: 2.953

Review 7.  Female Sexual Function at Midlife and Beyond.

Authors:  Holly N Thomas; Genevieve S Neal-Perry; Rachel Hess
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

Review 8.  Sexual counselling for sexual problems in patients with cardiovascular disease.

Authors:  Molly Byrne; Sally Doherty; Bengt G A Fridlund; Jan Mårtensson; Elaine E Steinke; Tiny Jaarsma; Declan Devane
Journal:  Cochrane Database Syst Rev       Date:  2016-02-24

9.  Patient preference and satisfaction in erectile dysfunction therapy: a comparison of the three phosphodiesterase-5 inhibitors sildenafil, vardenafil and tadalafil.

Authors:  Amr Abdel Raheem; Philip Kell
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

Review 10.  Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.

Authors:  R Sadovsky; G B Brock; S W Gutkin; S Sorsaburu
Journal:  Int J Clin Pract       Date:  2009-08       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.